chrisvoncsefalvay/vaers-outcomes huggingface dataset:
IMMEDIATELY AFTER SHOT THERE WAS SWELLING AND A BRUISE THAT LASTED FOR 2 WEEKS. WHEN THE SWELLING AND BRUISE BEGIN TO GO AWAY PAIN BEGIN IN THE JOINTS OF MY KNEES, SHOULDERS, ELBOWS, AND HANDS ALONG WITH SWELLING SO SEVERE I CANNOT BEND MY FINGERS OR RAISE MY ARMS ABOVE MY SHOULDERS IN THE MORNINGS. I SAW MY DOCTOR TWICE FOR THESE PROBLEMS BEFORE BLACKING OUT AND FALLING. I WAS HOSPITALIZATED OVERNIGHT. ALL TESTS AND SCANS HAVE COME BACK COMPLETELY NORMAL. THE DOCTOR THINKS THE VIRUS HAS SETTLED IN MY JOINTS. THIS PAIN HAS BEEN CONSTANT AND ONGOING FOR 3 WEEK.  12/5/08 Reviewed hospital medical records of 11/13-11/14/2008. FINAL DX: syncope, probable vasovagal; facial contusion; severe myalgia w/muscle weakness. Records reveal patient experienced syncope in shower, fall, unconsciousness, facial contusions w/nasal laceration & leg pain x 1 day.  Also complaining of joint aching, muscle aching since 10/28.  Had been tx by PCP as outpatient w/antibiotics & steroids which helped but when steroids tapered, symptoms recurred.  No further episodes while hospitalized.  D/C to home w/referral to neuro as outpatient.
Slightly dizziness; running nose; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6205, expiration date not reported), via an unspecified route of administration, administered on the left arm on 03Mar2021 16:15 (at the age of 64-years-old), as first dose, single dose for COVID-19 immunisation. Medical history included high blood pressure (hypertension). The patient previously took meloxicam (manufacturer unknown) and experienced drug hypersensitivity. The patient received other unspecified medications within 2 weeks of vaccination. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced slightly dizziness and running nose on 05Mar2021 07:00. Events did not result to physician office visit and emergency room visit. No treatment was given as a result of the events. The outcome of all events reported was unknown.  No follow-up attempts are possible. No further information is expected.
pt recv vax & devel severe abd pain;pt hosp & dx w/kidney failure;
Severe joint and muscle pain, fatigue/malaise, nausea, abdominal cramping worsening on 11/15-11/16.  Relieved by Benadryl.
I received my 2nd dose of the Pfizer vaccine on April 1 2021 around 8:00 a.m. At approximately 8:00 pm. I went to bed, within 1 hour I started having chills, within 2 hours I started sweating. Within 3 hours of going to bed I started vomiting every hour on the hour, until 8:00 a.m. on April 2nd 2021. During that time, my temperature got to 102.5...The sweating and chills, lasted until April 4th 2021, with my temperature getting down to 96.5...During this time and the next 2 weeks, I've had headaches on &  off for about a month now. Today, I actually have pain in the injection site, after 1 month of getting the shot, not sure if this is normal?
Pt reported to have received the Anthrax vaccine in the early stages of her pregnancy (before she was aware of the pregnancy). She was vaccinated in the military and informed our practice of vaccination at 1st visit on 8/12/16 at 32 wks pregnant.
mental health side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of MENTAL DISORDER (mental health side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced MENTAL DISORDER (mental health side effects). At the time of the report, MENTAL DISORDER (mental health side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Body aches, chills, fever up to 101°. Started about 26 hours after the injection. The fever lasted about 12 hours.
A report has been received from a Health Professional concerning a 10 year old, Male subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent started on an unknown date. It was reported that the physician had accidentally administered expired FLUMIST to two patients which started on 06-Jan-2015. The outcome of the event of accidentally administered expired FLUMIST to two patients was unknown. The report was considered to be non-serious.
Extreme dizziness on March 8th which progressively diminished the next 10 days.  After 10 days, dizziness was gone.  No specific treatment.
Armpit swollen, fever, headache, all muscles sore starting 12h after 2nd shot of Moderna. Fèver and headaches disappeared 24h after vaccine thanks to Tylenol but arm still swollen and sore after 84 hours.
I received my 1st booster on 11/11/2021 My adverse event started on 11/13/2021. I had flu like symptoms after the shot. On Saturday at  9:00AM I was out of breath (light headed). I laid down for 5-10 minutes. It didn't help. It wasn't normal. Then, I scheduled an appointment to my doctor said it might be asthma or allergies. She prescribed me albuterol which made it worse. I was out of breath even when I went home. I couldn't do anything. On Tuesday morning I went to ER there they did a lot blood tests and other tests and found out I had blood clots. I had constant chest pain. I am on blood thinners for rest of my heart. I am going to see my cardiologist to find out if I will have heart attack or not. For next couple of months I will be having heart imaging and other tests. I had done blood work before everything was fine but after the booster shot I had blood work done this is how we found out I had severe  reaction from the booster.
Sometime during March, I felt like a bruise on my leg near my ankle on the inside, and it turned to bright pink, and it stayed that way. In June I went to the ER because I had a chemical burn, while I was there I showed the doctor the thing on my leg because it was getting warm and I thought it was a blood clot. They said it was an Erythema nodosum. They told me to go to my doctor so I did go next week. They ordered a chest x-ray and did some blood work and referred me to a dermatologist. I went in mid July, and they did a punch biopsy and they told me it was Panniculitis and they wanted to do an incisional biopsy, they said it was Lipodermatosclerosis.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 30-JUL-2018, the patient was vaccinated with an improperly stored dose of ROTATEQ (strength were unknown) (lot# N030174 and expiration date 13-JUN-2019) orally for prophylaxis. The MERCK STERILE DILUENT (lot# and expiration date were unknown) was properly stored. No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018 was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001958.
After receiving 3rd injection of LymeRix pt reported arthralgia lasting 2 to 4 weeks. End of October pt received Influenza vaccine pt experienced arthralgia then dysesthsias. Pt has experienced spasms.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. No medical history and concurrent conditions were reported. On 16-OCT-2015 the patient was vaccinated with first dose of VAQTA (lot number and expiry date unknown) (dosing regimen and frequency unknown). No concomitant medications were reported. On 02-MAR-2016 the patient inadvertently received the second dose of VAQTA immunization series (lot number L043209, expiry date unknown) one month too early. No adverse effects were reported. The action taken with the therapy with VAQTA was unknown. The outcome of the events was unknown. The relatedness of the events to the therapy with VAQTA was unknown. There was no product quality complaint reported. It a was also reported that the physician had completed a VAERS report for this incident. Additional information has been requested.
This case was reported by a pharmacist and described the occurrence of red rash injection site in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). In October 2008, the subject received a dose of FLUARIX (.5 ml, unknown). In October 2008, at an unspecified time after vaccination with FLUARIX, the subject experienced red rash injection site and pharmaceutical product complaint. The pharmacist received a call from a nurse at a nursing home facility that reported that 80 out of 100 subjects developed a "grapefruit size bright red" rash at the injection site. At the time of reporting the outcome of the events were unspecified. For the other 79 linked subjects please see cases: A0756483A - A0756518A, A0756520 - A0756562A. The CRC provided lot number AFLUA3208A to QA regarding this complaint, while the report received in CMG Safety stated AFLUA3508A. With a possibility of a coding mistake to batch AFLUA320AA and on the basis that there are 80 cases out of 100, it was decided to ask for a Quality investigation (including cold chain) of all three batches (correct numbers: AFLUA350BA, AFLUA320BA and AFLUA320AA). On 16 January 2009, QA results were received for batches reviewed of (AFLUA320AA and AFLUA320BA): AFLUCA320, AFLUA320A, and AFLUA320B. The report indicated that no deviation that could be linked to the complaint and no cold chain deviation was recorded on the batches AFLUA320AA and AFLUA320BA. On 26 March 2009, QA results were received for batches reviewed (AFLUA350BA): AFLUCA350 and AFLUA350B. The report indicated that no deviation that could be linked to the complaint and no cold chain deviation was recorded on the batch AFLUC350BA.
No additional AE reported; A vaccine specialist reported ROTATEQ was improperly stored and administered; This spontaneous report has been received from a consumer concerning a patient of unknown age and gender. The patient's concurrent conditions, historical drugs, medical history and concomitant therapies were not reported.    On 17-DEC-2020, the patient was vaccinated with an improperly stored rotavirus vaccine, live, oral, pentavalent(ROTATEQ) Lot # 1661000 expiration date 13-MAY-2021 for prophylaxis(dosage regimen and anatomical location were not reported).  The temperature was reported to had been at 46.8°Fahrenheit (F) for 10 minutes.  No additional adverse events were reported.  There was digital data logger involved and no previous temperature excursion was reported.
Two days later I had chest tightness for less than 1 minute. Two weeks later I had loss of sensation in both arms that lasted for 6 hours.   All resolved now.
rt thigh @ inject of DTP sl red w/knot palpated @ approx 1 1/2cm in diameter; pt seen by MD;
dime-sized hair loss patch rt occiput discovered MAR95;progressed to 3inch patch w/scattered pea size patches & loss of back hairline;dx as alopecia areata;JAN96 hair loss patch discovered @ middle back of hairline;
PATIENT WAS DIAGNOSED WITH SHINGLES AFTER RECEIVING ZOSTAVAX.  T10 DERMATOME, PAIN 4/10; RASH AND PAIN RESOLVED WITHOUT COMPLICATION OTHER THAN SCARRING.
On 4.9.21, Friday,  client received her first Pfizer-BioNTech COVID-19 Vaccine at 1539 with lot number ER8731. Client reported to EMT  feeling anxious and ?trapped.? Client also reported feeling a burning feeling in chest, hot and sweaty, and nauseated. Medical history was reviewed noting a history of seizures in November, anxiety, and heart problems. Reported takes 75mg antidepressant, indigestion medications, and "effexor." Client remained alert and oriented x3 with the following vital signs: blood pressure 148/118 and pulse of 110. Client reported that had drank ?half a pot of coffee.? Vital signs at 1600 were blood pressure of 120/98 and pulse of 100 and client noted that all symptoms went away. Then at 1609 client reported chest burning sensation, EMT offered EMS which client accepted. No medications were given by county staff. At 1612 EMS was called to site and arrived at 1616. Vital signs at 1620 were blood pressure of 107/96 and pulse of 112. Client then refused transport at 1622. After EMS left client took own supply of 1 tablet of expired Xanax. Client was noted to have steady gait while leaving site.
Bumps on arm itching, rash in the AM on the edge of inj site and beyond. Itchy, red, warm to touch
Hives from knees to shoulders, starting 3 months after second injection. Skin biopsy shows hypersensitivity only. Treatment has been with oral steroids, Medrol shot and antihistamines without much change. There have been no major changes in my daily routine to suggest an allergy to something.
Feels tense again now; Extremely weak (very weak)/Weakness/Wanting to lie down that lasted 24 hours; Tiredness; Cannot go due to fear of side effects/Terrorized to get 2nd dose; Extreme chills; Shaking/trembling; "All my body was stiff"; Not possible to stretch legs; Not possible to breath in and out/Not possible to calm down; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking/trembling), MUSCULOSKELETAL STIFFNESS ("All my body was stiff"), LIMB DISCOMFORT (Not possible to stretch legs), DYSPNOEA (Not possible to breath in and out/Not possible to calm down) and TENSION (Feels tense again now) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (between 13 and 15th) in December 2020. Concurrent medical conditions included Blood pressure and Cholesterol. Concomitant products included ROSUVASTATIN for Hyperlipidemia, OLMESARTAN for Hypertension.    On 28-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jun-2021, the patient experienced TREMOR (Shaking/trembling), MUSCULOSKELETAL STIFFNESS ("All my body was stiff"), LIMB DISCOMFORT (Not possible to stretch legs) and DYSPNOEA (Not possible to breath in and out/Not possible to calm down). On an unknown date, the patient experienced TENSION (Feels tense again now), HEART RATE INCREASED (heartbeat was fast at times), ASTHENIA (Extremely weak (very weak)/Weakness/Wanting to lie down that lasted 24 hours), FATIGUE (Tiredness), FEAR (Cannot go due to fear of side effects/Terrorized to get 2nd dose) and CHILLS (Extreme chills). At the time of the report, TREMOR (Shaking/trembling), MUSCULOSKELETAL STIFFNESS ("All my body was stiff"), LIMB DISCOMFORT (Not possible to stretch legs), DYSPNOEA (Not possible to breath in and out/Not possible to calm down), TENSION (Feels tense again now), HEART RATE INCREASED (heartbeat was fast at times), ASTHENIA (Extremely weak (very weak)/Weakness/Wanting to lie down that lasted 24 hours), FATIGUE (Tiredness), FEAR (Cannot go due to fear of side effects/Terrorized to get 2nd dose) and CHILLS (Extreme chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient did not receive treatment for the adverse events.
Have been running a persistent temp of 98.8-99.1 since vaccine. My normal is 97.4-97.6. Fatigue,  low grade temp, headache, nausea, body aches, sore throat, headache, very sore arm and shoulder pain all came on within hours of vaccine. Lost feeling in my left pinky and my whole left side felt strange. Vaccine was given in my left arm. Regained that feeling in pinky 04/16. Feel heavy and slow, almost like I need to remind myself to breathe sometimes. Woke up 04/16 with strong dizziness/vertigo feeling. Have had persistent feeling of heartburn since the shot. Will be going to my PCP if does not subside and get better.
This spontaneous case reported by a nurse, describes the occurrence of administered expired product  (318 patients received dose from vials beyond 30-day use by date) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 037C21A) for COVID-19 immunization. No medical history reported. On Jun 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On Jun 9, 2021, patient administered expired product (318 patients received dose from vials beyond 30-day use by date). On Jun 9, 2021, administered expired product (318 patients received dose from vials beyond 30-day use by date) resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information. This case linked to MOD-2021-364601 (patient link).
Arm still hurts; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In December 2021, the patient received Shingles vaccine. In December 2021, less than a week after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for himself/herself. The age at vaccination was not reported. The patient said his/her arm still hurts from the vaccine after 3 days. The follow-up could not be possible as no contact details were available.
has not eaten yet only drank a lot of fluids; cough; nausea; fatigue,feel tired; fever up to 100.8F; chills,; Since Friday night she has been experiencing symptoms that have been increasing; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Since Friday night she has been experiencing symptoms that have been increasing), DECREASED APPETITE (has not eaten yet only drank a lot of fluids), COUGH (cough), NAUSEA (nausea) and FATIGUE (fatigue,feel tired) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. EM9810) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression and Pain.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 19-Feb-2021, the patient experienced ADVERSE EVENT (Since Friday night she has been experiencing symptoms that have been increasing), COUGH (cough), NAUSEA (nausea), FATIGUE (fatigue,feel tired), PYREXIA (fever up to 100.8F) and CHILLS (chills,). On 22-Feb-2021, the patient experienced DECREASED APPETITE (has not eaten yet only drank a lot of fluids). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ADVERSE EVENT (Since Friday night she has been experiencing symptoms that have been increasing), DECREASED APPETITE (has not eaten yet only drank a lot of fluids), COUGH (cough), NAUSEA (nausea), FATIGUE (fatigue,feel tired), PYREXIA (fever up to 100.8F) and CHILLS (chills,) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Pyrexia: 100.8 (High) 100.8F.         Treatment details included paracetamol and cough medicine. Action taken with mRNA-1273 in response to the events was not applicable.
I had COVID-19 arm after the booster shot. All my previous symptoms from the first shot worsened. I did not seek any care.
The first day of the reaction started out with a mild back ache. The pain level of the back ache increased significantly in the following three days, at times reaching  a level 10 on a scale of one to ten. I tried to alleviate the pain by taking 800 mg of ibuprofen, but it did nothing.
Day following vaccine injection, reported elevated temperate of greater than 100, no appetite, this resolved without treatment
She got her vaccine, her arm was sore.  The next day she had a terrible headache, and had that every day for 7 days, and never gets headaches.  She had nausea and muscle aches in her legs, neck and arms for 7 days.   The pharmacist who gave her the shot never told her about side effects.  It was so bad and thought she had COVID, which she took a test and it was negative.  After 7 days her symptoms went away slowly, and she is OK now.    She called her son who is a doctor and researched it and felt that it was more than likely the shingles vaccine that gave her the reaction.
patient only received the MenA conjugate along with a diluent, instead of the MenCYW-135 liquid conjugate component; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 15-MAY-2023, the patient received Menveo. On 15-MAY-2023, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: patient only received the MenA conjugate along with a diluent, instead of the MenCYW-135 liquid conjugate component). The outcome of the wrong solution used in drug reconstitution was unknown.   Additional Information: GSK Receipt Date: 18-MAY-2023 The reporter did not know which diluent was used. The reporter consented to follow up. The patient received the MenA conjugate along with a diluent, instead of the MenCYW-135 liquid conjugate component, which led to wrong solution used in drug reconstitution.
Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Patient was given KINRIX (Dtap/IPV) on 8/25/14. Had reaction redness and swelling at injection site on 8/27/14. 5 1/4 x 4 in. erythematous warm localized reaction.
SOB/wheezing; ear throbbing/sore throat; increase heart rate; chills; inflammation of salivary glands.
Day after injection some knotting and warmth in area;  8th day itching, warmth and knot/swelling returned and knot/swelling was larger---  "COVID arm"-- antihistamine taken and sweling/knot, heat and itching is resolving
Chills, vomiting, headaches. Menstruation cycles are heavier, they come once or twice a month or not at all. Nightmares.